ResMed (RMD) PT Lowered to $210 at BofA Securities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. S
6. RBRK
7. GAP
8. DG
9. ULTA
10. ADSK

June 15, 2022 5:35 AM EDT
Get Alerts RMD Hot Sheet
Price: $239.23 +1.47%

Rating Summary:
    11 Buy, 13 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 5 | Down: 4 | New: 3
Join SI Premium – FREE
BofA Securities analyst Lyanne Harrison lowered the price target on ResMed (NYSE: RMD) to $210.00 (from $230.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change